¹û¶³Ó°Ôº

1/ Studies hosted at ¹û¶³Ó°ÔºH.

2/ Studies where the sponsor is ¹û¶³Ó°Ôº and ¹û¶³Ó°ÔºH sponsored studies.

3/ Monitoring visits at ¹û¶³Ó°ÔºH.

Further information can also be found on our Covid-19 web pages.

The guidance documents have not changed from those circulated earlier this year and should continue to be applied for all future surges and/or where Covid related activity impacts NHS clinical delivery.

Please do follow the appropriate guidance for the study:

• Studies sponsored by ¹û¶³Ó°Ôº or ¹û¶³Ó°ÔºH with sites outside of ¹û¶³Ó°ÔºH should follow the guidance against point 2 (in the list above) and the local policy/guidance of the host NHS or Social Care organisations.
• Studies sponsored by ¹û¶³Ó°Ôº or ¹û¶³Ó°ÔºH and where the site is ¹û¶³Ó°ÔºH should follow guidance 1, 2 and where applicable guidance 3
• Studies sponsored by an organisation outside of ¹û¶³Ó°Ôº and ¹û¶³Ó°ÔºH and where ¹û¶³Ó°ÔºH is a site, should follow guidance 1 and where applicable guidance 3.

Studies which are supported by a ¹û¶³Ó°Ôº Clinical Trials Unit (CTU) should consult with the CTU point of contact prior to initiating guidance 2.

Should there be any change to the guidance the JRO will email all researchers and research groups and will update the JRO website.

To be included in future communications about Covid-19 and research, please email uclh.jro-communications@nhs.net and ask to be included in the researchers’ distribution list.

For any questions email Rajinder Sidhu on r.sidhu@nhs.net and Pushpsen Joshi on pushpsen.joshi@nhs.net.